Barclays
USNA icon

Barclays’s Usana Health Sciences USNA Stock Holding History

Barclays’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-600
Closed -$26K – 7693
2013
Q3 		$26K Sell
600
-2,800
-82% -$112K ﹤0.01% 6414
2013
Q2 		$123K Buy
+3,400
New +$103K ﹤0.01% 5615

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's USNA Position: Q1 2026 in Review

Barclays reduced its Usana Health Sciences (USNA) stake by 28% in Q1 2026, selling an estimated $278K and leaving 35,241 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

Barclays first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.85M in Q2 2014. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Barclays held 35,241 shares of Usana Health Sciences worth $616K as of Q1 2026.
  • Barclays sold 14,030 Usana Health Sciences shares in Q1 2026, an estimated $278K.
  • Usana Health Sciences made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3064 holding.
  • Barclays first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Usana Health Sciences position peaked at $3.85M in Q2 2014.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.